{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T19:14:41Z","timestamp":1783538081016,"version":"3.55.0"},"reference-count":77,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1652,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1111\/j.1365-2516.2011.02504.x","type":"journal-article","created":{"date-parts":[[2011,2,23]],"date-time":"2011-02-23T18:17:35Z","timestamp":1298485055000},"page":"910-919","source":"Crossref","is-referenced-by-count":34,"title":["Elective orthopaedic surgery for haemophilia patients with inhibitors: single centre experience of 40 procedures and review of the literature"],"prefix":"10.1111","volume":"17","author":[{"given":"H.","family":"CAVIGLIA","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"CANDELA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"GALATRO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"NEME","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"MORETTI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. P.","family":"BIANCO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,2,22]]},"reference":[{"key":"10.1111\/j.1365-2516.2011.02504.x-BIB1|cit1","first-page":"27","volume-title":"Hemophilia in the Child and Adult","author":"Gill","year":"1989"},{"key":"10.1111\/j.1365-2516.2011.02504.x-BIB2|cit2","unstructured":"World Federation of Hemophilia Guidelines for the Management of Hemophilia http:\/\/www.wfh.org\/2\/docs\/Publications\/Diagnosis_and_Treatment\/Guidelines_Mng_Hemophilia.pdf"},{"key":"10.1111\/j.1365-2516.2011.02504.x-BIB3|cit3","volume-title":"The Management of Musculoskeletal Problems in the Haemophilias","author":"Duthie","year":"1994"},{"key":"10.1111\/j.1365-2516.2011.02504.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1046\/j.1423-0410.1999.7730131.x","article-title":"Use of recombinant, activated factor VII in the treatment of congenital factor VII deficiencies","volume":"77","author":"Mariani","year":"1999","journal-title":"Vox Sang"},{"key":"10.1111\/j.1365-2516.2011.02504.x-BIB5|cit5","first-page":"15","article-title":"Hemophilia. Strategies for the treatment of inhibitor patients","volume":"85","author":"Ingerslev","year":"2000","journal-title":"Haematologica"},{"issue":"Suppl. 1","key":"10.1111\/j.1365-2516.2011.02504.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1053\/j.seminhematol.2008.03.009","article-title":"Controversies and challenges in elective orthopedic surgery in patients with hemophilia and inhibitors","volume":"45","author":"Jim\u00e9nez-Yuste","year":"2008","journal-title":"Semin Hematol"},{"key":"10.1111\/j.1365-2516.2011.02504.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1046\/j.1365-2141.2003.04173.x","article-title":"A prospective study of recombinant activated factor VII administered by continuous infusion to inhibitor patients undergoing elective major orthopaedic surgery: a pharmacokinetic and efficacy evaluation","volume":"120","author":"Ludlam","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1365-2516.2011.02504.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1055\/s-0037-1615357","article-title":"Prospective, randomised trial of two doses of rFVIIa (NovoSeven) in haemophilia patients with inhibitors undergoing surgery","volume":"80","author":"Shapiro","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1365-2516.2011.02504.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1160\/TH07-03-0198","article-title":"Haemostatic efficacy and safety of bolus and continuous infusion of recombinant factor VIIa are comparable in haemophilia patients with inhibitors undergoing major surgery. Results from an open-label, randomized, multicenter trial","volume":"98","author":"Pruthi","year":"2007","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1365-2516.2011.02504.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/9780470757260.ch27","volume-title":"Inhibitors in Patients with Haemophilia","author":"Hvid","year":"2002"},{"key":"10.1111\/j.1365-2516.2011.02504.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/978-3-642-79009-6_21","volume-title":"25 Hamophilie Symposium","author":"Ingerslev","year":"1994"},{"issue":"Suppl. 1","key":"10.1111\/j.1365-2516.2011.02504.x-BIB12|cit12","first-page":"118","article-title":"Major surgery in haemophilic patients with inhibitors using recombinant factor VIIa","volume":"26","author":"Ingerslev","year":"1996","journal-title":"Haemostasis"},{"key":"10.1111\/j.1365-2516.2011.02504.x-BIB13|cit13","first-page":"926","article-title":"[Perioperative use of recombinant activated factor VII (rF VIIa) in a patient with hemophilia A having inhibitors]","volume":"54","author":"Kawasaki","year":"2005","journal-title":"Masui"},{"key":"10.1111\/j.1365-2516.2011.02504.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0300-2977(98)00111-9","article-title":"Continuous infusion of recombinant factor VIIa in patients with haemophilia and inhibitors: experience in The Netherlands and Belgium","volume":"53","author":"Mauser-Bunschoten","year":"1998","journal-title":"Neth J Med"},{"issue":"Suppl. 1","key":"10.1111\/j.1365-2516.2011.02504.x-BIB15|cit15","first-page":"109","article-title":"Experience with recombinant factor VIIa in Australia and New Zealand","volume":"26","author":"McPherson","year":"1996","journal-title":"Haemostasis"},{"key":"10.1111\/j.1365-2516.2011.02504.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.2106\/00004623-200411000-00026","article-title":"Total knee arthroplasty using recombinant factor VII in hemophilia-A patients with inhibitors. A report of three cases","volume":"86-A","author":"Mehta","year":"2004","journal-title":"J Bone Joint Surg Am"},{"key":"10.1111\/j.1365-2516.2011.02504.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1046\/j.0007-1048.2001.03297.x","article-title":"Massive pseudotumour resection with recombinant factor VIIa (NovoSeven) cover","volume":"116","author":"O\u2019Connell","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1365-2516.2011.02504.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0025-6196(12)61340-8","article-title":"Successful hemostasis during a major orthopedic operation by using recombinant activated factor VII in a patient with severe hemophilia A and a potent inhibitor","volume":"69","author":"O\u2019Marcaigh","year":"1994","journal-title":"Mayo Clin Proc"},{"key":"10.1111\/j.1365-2516.2011.02504.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1046\/j.1365-2516.2002.00690.x","article-title":"Sequential treatment with bolus and continuous infusion of recombinant factor VIIa for hip arthroplasty in a patient with haemophilia A and inhibitor","volume":"8","author":"Perez","year":"2002","journal-title":"Haemophilia"},{"issue":"Suppl. 2","key":"10.1111\/j.1365-2516.2011.02504.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1365-2516.2004.00938.x","article-title":"Surgery in haemophilic patients with inhibitor: 20\u2003years of experience","volume":"10","author":"Quintana-Molina","year":"2004","journal-title":"Haemophilia"},{"key":"10.1111\/j.1365-2516.2011.02504.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/j.1365-2516.2007.01520.x","article-title":"Orthopaedic surgery for inhibitor patients: a series of 27 procedures (25 patients)","volume":"13","author":"Rodriguez-Merchan","year":"2007","journal-title":"Haemophilia"},{"key":"10.1111\/j.1365-2516.2011.02504.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1046\/j.1365-2516.2003.00803.x","article-title":"Elective orthopaedic surgery for inhibitor patients","volume":"9","author":"Rodriguez-Merchan","year":"2003","journal-title":"Haemophilia"},{"key":"10.1111\/j.1365-2516.2011.02504.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1046\/j.1365-2516.2003.00693.x","article-title":"Efficacy of NovoSeven during surgery on a haemophiliac with previous history of inhibitors","volume":"9","author":"Saba","year":"2003","journal-title":"Haemophilia"},{"key":"10.1111\/j.1365-2516.2011.02504.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1365-2516.2007.01619.x","article-title":"One-stage replacement of infected knee prosthesis in a patient with haemophilia A and high titre of inhibitors","volume":"14","author":"Sartori","year":"2008","journal-title":"Haemophilia"},{"key":"10.1111\/j.1365-2516.2011.02504.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1055\/s-0038-1650292","article-title":"Feasibility of using recombinant factor VIIa in continuous infusion","volume":"75","author":"Schulman","year":"1996","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1365-2516.2011.02504.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1055\/s-0038-1642400","article-title":"Recombinant factor VIIa in multiple surgery","volume":"71","author":"Schulman","year":"1994","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1365-2516.2011.02504.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/9780470986929.ch9","volume-title":"The Haemophilic Joints: New Perspectives","author":"Schulmann","year":"2003"},{"key":"10.1111\/j.1365-2516.2011.02504.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/j.1460-9592.2007.02220.x","article-title":"The intraoperative use of recombinant FVIIa in child with hemophilia A with antibodies","volume":"17","author":"Simic","year":"2007","journal-title":"Paediatr Anaesth"},{"key":"10.1111\/j.1365-2516.2011.02504.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1055\/s-0037-1616516","article-title":"Elective surgery on factor VIII inhibitor patients using continuous infusion of recombinant activated factor VII: plasma factor VII activity of 10\u2003IU\/ml is associated with an increased incidence of bleeding","volume":"86","author":"Smith","year":"2001","journal-title":"Thromb Haemost"},{"issue":"Suppl. 3","key":"10.1111\/j.1365-2516.2011.02504.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1365-2516.2006.01267.x","article-title":"Total joint replacement in patients with inhibitors","volume":"12","author":"Solimeno","year":"2006","journal-title":"Haemophilia"},{"issue":"Suppl. 1","key":"10.1111\/j.1365-2516.2011.02504.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1365-2516.2005.01151.x","article-title":"Rehabilitation of patients with haemophilia after orthopaedic surgery: a case study","volume":"11","author":"Stephensen","year":"2005","journal-title":"Haemophilia"},{"key":"10.1111\/j.1365-2516.2011.02504.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1365-2516.2007.01476.x","article-title":"Orthopaedic limb salvage with a mega prosthesis in a patient with haemophilia A and inhibitors - a case report","volume":"13","author":"Stumpf","year":"2007","journal-title":"Haemophilia"},{"key":"10.1111\/j.1365-2516.2011.02504.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1046\/j.1351-8216.2003.00820.x","article-title":"Concurrent total hip and knee replacements in a patient with haemophilia with inhibitors using recombinant factor VIIa by continuous infusion","volume":"9","author":"Tagariello","year":"2003","journal-title":"Haemophilia"},{"key":"10.1111\/j.1365-2516.2011.02504.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1046\/j.1365-2516.2000.00400.x","article-title":"Recombinant FVIIa (NovoSeven) continuous infusion and total hip replacement in patients with haemophilia and high titre of inhibitors to FVIII: experience of two cases","volume":"6","author":"Tagariello","year":"2000","journal-title":"Haemophilia"},{"key":"10.1111\/j.1365-2516.2011.02504.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1600-0609.1998.tb01105.x","article-title":"Optimal care of inhibitor patients during surgery","volume":"63","author":"Vermylen","year":"1998","journal-title":"Eur J Haematol Suppl"},{"key":"10.1111\/j.1365-2516.2011.02504.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/j.1365-2516.2004.01037.x","article-title":"Management of haemophilic patients with inhibitors in major orthopaedic surgery by immunadsorption, substitution of factor VIII and recombinant factor VIIa (NovoSeven): a single centre experience","volume":"10","author":"Habermann","year":"2004","journal-title":"Haemophilia"},{"key":"10.1111\/j.1365-2516.2011.02504.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1365-2516.2007.01617.x","article-title":"Recombinant activated factor VII for haemophilia patients with inhibitors undergoing orthopaedic surgery: a review of the literature","volume":"14","author":"Obergfell","year":"2008","journal-title":"Haemophilia"},{"key":"10.1111\/j.1365-2516.2011.02504.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1046\/j.0007-1048.2001.03324.x","article-title":"Recombinant factor VIIa in the management of surgery and acute bleeding episodes in children with haemophilia and high responding inhibitors","volume":"116","author":"O\u2019Connell","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1365-2516.2011.02504.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1097\/00001721-200412000-00009","article-title":"Intestinal surgery with activated recombinant factor VII prophylaxis in patients with haemophilia A and high responding inhibitors: a report of five cases","volume":"15","author":"Slaoui","year":"2004","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1111\/j.1365-2516.2011.02504.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/00001721-200104000-00009","article-title":"Successful use of recombinant factor VIIa in a haemophiliac with inhibitor undergoing cataract surgery","volume":"12","author":"Biron-Andreani","year":"2001","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1111\/j.1365-2516.2011.02504.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1046\/j.1365-2516.2001.00501.x","article-title":"Knee joint arthroplasty in a patient with haemophilia A and high inhibitor titre using recombinant factor VIIa (NovoSeven): a new case report and review of the literature","volume":"7","author":"Faradji","year":"2001","journal-title":"Haemophilia"},{"key":"10.1111\/j.1365-2516.2011.02504.x-BIB42|cit42","first-page":"1","article-title":"Failure of recombinant activated factor VII during surgery in a hemophiliac with high-titer factor VIII antibody","volume":"21","author":"Gringeri","year":"1991","journal-title":"Haemostasis"},{"key":"10.1111\/j.1365-2516.2011.02504.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1365-2516.2005.01052.x","article-title":"Treatment of factor XI inhibitor using recombinant activated factor VIIa","volume":"11","author":"Bern","year":"2005","journal-title":"Haemophilia"},{"key":"10.1111\/j.1365-2516.2011.02504.x-BIB44|cit44","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/BF02981987","article-title":"Successful use of recombinant factor VIIa for hemostasis during total knee replacement in a severe hemophiliac with high-titer factor VIII inhibitor","volume":"75","author":"Carr","year":"2002","journal-title":"Int J Hematol"},{"key":"10.1111\/j.1365-2516.2011.02504.x-BIB45|cit45","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1046\/j.1365-2516.2001.00553.x","article-title":"Rationale for the use of high dose rFVIIa in a high-titre inhibitor patient with haemophilia B during major orthopaedic procedures","volume":"7","author":"Cooper","year":"2001","journal-title":"Haemophilia"},{"key":"10.1111\/j.1365-2516.2011.02504.x-BIB46|cit46","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1365-2516.2006.01284.x","article-title":"A retrospective postlicensure survey of FEIBA efficacy and safety","volume":"12","author":"Dimichele","year":"2006","journal-title":"Haemophilia"},{"issue":"Suppl. 1","key":"10.1111\/j.1365-2516.2011.02504.x-BIB47|cit47","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1365-2516.2005.01155.x","article-title":"Case studies: orthopaedic surgery in adult patients with haemophilia A with inhibitors","volume":"11","author":"Goddard","year":"2005","journal-title":"Haemophilia"},{"key":"10.1111\/j.1365-2516.2011.02504.x-BIB48|cit48","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1046\/j.1365-2516.1999.00368.x","article-title":"Hemophilia. Treatment of patients with inhibitors: cost issues","volume":"5","author":"Goudemand","year":"1999","journal-title":"Haemophilia"},{"issue":"Suppl. 2","key":"10.1111\/j.1365-2516.2011.02504.x-BIB49|cit49","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1365-2516.2004.00940.x","article-title":"Cases of surgery in high-responder haemophilia patients","volume":"10","author":"Goudemand","year":"2004","journal-title":"Haemophilia"},{"key":"10.1111\/j.1365-2516.2011.02504.x-BIB50|cit50","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/00001721-199008000-00009","article-title":"Factor VIIa in the treatment of haemophilia","volume":"1","author":"Hedner","year":"1990","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1111\/j.1365-2516.2011.02504.x-BIB51|cit51","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/S0140-6736(88)90259-0","article-title":"Successful use of recombinant factor VIIa in patient with severe haemophilia A during synovectomy","volume":"2","author":"Hedner","year":"1988","journal-title":"Lancet"},{"issue":"Suppl. 1","key":"10.1111\/j.1365-2516.2011.02504.x-BIB52|cit52","first-page":"S129","article-title":"Levels of prothrombin activation peptide F1+2 in patients with a bleeding tendency","volume":"9","author":"Ingerslev","year":"1998","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"Suppl. 1","key":"10.1111\/j.1365-2516.2011.02504.x-BIB53|cit53","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1159\/000056715","article-title":"Treatment of acute bleeding episodes with rFVIIa","volume":"77","author":"Ingerslev","year":"1999","journal-title":"Vox Sang"},{"key":"10.1111\/j.1365-2516.2011.02504.x-BIB54|cit54","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1046\/j.1365-2516.2002.00649.x","article-title":"Approaches to successful total knee arthroplasty in haemophilia A patients with inhibitors","volume":"8","author":"Konkle","year":"2002","journal-title":"Haemophilia"},{"key":"10.1111\/j.1365-2516.2011.02504.x-BIB55|cit55","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1046\/j.1365-2516.1999.t01-2-00294.x","article-title":"Postoperative use of rFVIIa by continuous infusion in a haemophilic boy","volume":"5","author":"Lorenzo","year":"1999","journal-title":"Haemophilia"},{"key":"10.1111\/j.1365-2516.2011.02504.x-BIB56|cit56","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1046\/j.1365-2516.2002.00667.x","article-title":"Efficacy of recombinant factor VIIa administered by continuous infusion to haemophilia patients with inhibitors","volume":"8","author":"Mauser-Bunschoten","year":"2002","journal-title":"Haemophilia"},{"key":"10.1111\/j.1365-2516.2011.02504.x-BIB57|cit57","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/00001721-199804000-00012","article-title":"Management of an anti-factor VIII inhibitor occurring during surgical procedure with continuous infusion of Novoseven","volume":"9","author":"Menart","year":"1998","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1111\/j.1365-2516.2011.02504.x-BIB58|cit58","first-page":"183","article-title":"[Continuous infusion of recombinant activated factor VII during and after elbow arthroplasty in a hemophilia A patient with inhibitors]","volume":"43","author":"Nakamura","year":"2002","journal-title":"Rinsho Ketsueki"},{"key":"10.1111\/j.1365-2516.2011.02504.x-BIB59|cit59","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1185\/030079908X273048","article-title":"Economic evaluation of major knee surgery with recombinant activated factor VII in hemophilia patients with high titer inhibitors and advanced knee arthropathy: exploratory results via literature-based modeling","volume":"24","author":"Ballal","year":"2008","journal-title":"Curr Med Res Opin"},{"key":"10.1111\/j.1365-2516.2011.02504.x-BIB60|cit60","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1182\/blood.V56.6.978.978","article-title":"Anti-inhibitor coagulant complex (Autoplex) for treatment of factor VIII inhibitors in hemophilia","volume":"56","author":"Abildgaard","year":"1980","journal-title":"Blood"},{"key":"10.1111\/j.1365-2516.2011.02504.x-BIB61|cit61","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S0750-7658(86)80097-1","article-title":"[Bilateral prosthesis of the knee in a hemophilia A patient with an inhibitor]","volume":"5","author":"Lauroua","year":"1986","journal-title":"Ann Fr Anesth Reanim"},{"key":"10.1111\/j.1365-2516.2011.02504.x-BIB62|cit62","first-page":"291","volume-title":"Factor VIII Inhibitors","author":"Penner","year":"1984"},{"key":"10.1111\/j.1365-2516.2011.02504.x-BIB63|cit63","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.1365-2516.2005.01141.x","article-title":"Major surgery in a severe haemophilia A patient with high titre inhibitor: use of the thrombin generation test in the therapeutic decision","volume":"11","author":"Dargaud","year":"2005","journal-title":"Haemophilia"},{"key":"10.1111\/j.1365-2516.2011.02504.x-BIB64|cit64","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1542\/peds.71.4.631","article-title":"Anti-inhibitor coagulant complex (Autoplex) in hemophilia inhibitor patients undergoing synovectomy","volume":"71","author":"Hutchinson","year":"1983","journal-title":"Pediatrics"},{"key":"10.1111\/j.1365-2516.2011.02504.x-BIB65|cit65","first-page":"338","article-title":"[Successful extirpation of femoral pseudotumour in a patient with severe haemophilia A and an inhibitor to factor VIII]","volume":"119","author":"Marisavljevic","year":"1991","journal-title":"Srp Arh Celok Lek"},{"key":"10.1111\/j.1365-2516.2011.02504.x-BIB66|cit66","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1046\/j.1365-2516.1999.00299.x","article-title":"Safety and efficacy of three arthroscopic procedures using Holmium: Yag laser in two high-responder haemophiliacs","volume":"5","author":"Menart","year":"1999","journal-title":"Haemophilia"},{"issue":"Suppl. 3","key":"10.1111\/j.1365-2516.2011.02504.x-BIB67|cit67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2516.1999.00036.x","article-title":"Management of haemophilia in patients with high-titre inhibitors: focus on the evolution of activated prothrombin complex concentrate AUTOPLEX T","volume":"5","author":"Penner","year":"1999","journal-title":"Haemophilia"},{"key":"10.1111\/j.1365-2516.2011.02504.x-BIB68|cit68","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/MPH.0b013e318041f101","article-title":"Use of FEIBA for invasive or surgical procedures in patients with severe hemophilia A or B with inhibitors","volume":"29","author":"Stine","year":"2007","journal-title":"J Pediatr Hematol Oncol"},{"issue":"2 Suppl. 4","key":"10.1111\/j.1365-2516.2011.02504.x-BIB69|cit69","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1053\/j.seminhematol.2006.03.003","article-title":"Surgery in patients with hemophilia and inhibitors: a review of the Norwegian experience with FEIBA","volume":"43","author":"Tjonnfjord","year":"2006","journal-title":"Semin Hematol"},{"key":"10.1111\/j.1365-2516.2011.02504.x-BIB70|cit70","first-page":"227","article-title":"Diagnosis and treatment of congenital hemophilia with inhibitors a Latin American perspective","volume":"68","author":"Perez Bianco","year":"2008","journal-title":"Medicina (B Aires)"},{"key":"10.1111\/j.1365-2516.2011.02504.x-BIB71|cit71","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1365-2516.2008.01952.x","article-title":"Consensus protocol for the use of recombinant activated factor VII [eptacog alfa (activated); NovoSeven] in elective orthopaedic surgery in haemophilic patients with inhibitors","volume":"15","author":"Giangrande","year":"2009","journal-title":"Haemophilia"},{"key":"10.1111\/j.1365-2516.2011.02504.x-BIB72|cit72","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1365-2516.2008.01840.x","article-title":"Orthopaedic surgery in haemophilia patients with inhibitors: a practical guide to haemostatic, surgical and rehabilitative care","volume":"15","author":"Teitel","year":"2009","journal-title":"Haemophilia"},{"key":"10.1111\/j.1365-2516.2011.02504.x-BIB73|cit73","first-page":"62","volume-title":"27 Hamophilie Symposium","author":"Ingerslev","year":"1997"},{"key":"10.1111\/j.1365-2516.2011.02504.x-BIB74|cit74","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1365-2516.2006.01421.x","article-title":"Successful concurrent triple surgery in an adolescent patient with haemophilia A and inhibitors treated with recombinant factor VIIa","volume":"13","author":"Janic","year":"2007","journal-title":"Haemophilia"},{"key":"10.1111\/j.1365-2516.2011.02504.x-BIB75|cit75","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1365-2516.2004.00784.x","article-title":"Excision of pseudotumour in a patient with haemophilia A and inhibitor managed with recombinant factor VIIa","volume":"10","author":"Takedani","year":"2004","journal-title":"Haemophilia"},{"issue":"1 Suppl. 1","key":"10.1111\/j.1365-2516.2011.02504.x-BIB76|cit76","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1053\/j.seminhematol.2003.11.020","article-title":"Elective orthopedic surgery for hemophilia patients with inhibitors: new opportunities","volume":"41","author":"Rodriguez-Merchan","year":"2004","journal-title":"Semin Hematol"},{"issue":"Suppl. 2","key":"10.1111\/j.1365-2516.2011.02504.x-BIB77|cit77","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1365-2516.2004.00941.x","article-title":"Consensus perspectives on surgery in haemophilia patients with inhibitors: summary statement","volume":"10","author":"Rodriguez-Merchan","year":"2004","journal-title":"Haemophilia"}],"container-title":["Haemophilia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2516.2011.02504.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2516.2011.02504.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T13:12:39Z","timestamp":1712236359000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2516.2011.02504.x"}},"subtitle":["EOS FOR HAEMOPHILIA PATIENTS WITH INHIBITORS"],"short-title":[],"issued":{"date-parts":[[2011,2,22]]},"references-count":77,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,11]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2516.2011.02504.x","relation":{},"ISSN":["1351-8216"],"issn-type":[{"value":"1351-8216","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2,22]]}}}